In ovo model for immuno-oncology screening
Inovotion seek partners to provide diverse, novel immuno-oncology compounds (with preclinical data available) to test their novel in ovo model.
Virtual Disease Laboratories: exploiting in silico models in the pharmaceutical industry
Simomics’ Virtual Disease Laboratory technology enables effective exploitation of in silico models, providing an online platform to explore, evidence, share and communicate the model and its results.
In vitro platform for retinal toxicity assessment and disease modelling
An end-user pharmaceutical company, able to provide access to ocular compounds and data with known in vivo/in vitro toxicity profiles, is sought to validate the model.
Assessing aquatic organism health status non-invasively
Collaborators are sought in any sector using aquatic animal health monitoring to assess and validate this eDNA metabarcoding technology against current practice.
Developing an automated test of recognition memory in rodents
Partnership is sought with a variety of users who can help further develop and validate the semi-automated ‘continual trials’ apparatus for spontaneous object recognition tasks.
A human micro-liver system for safety and efficacy testing
Industrial partners involved in drug development and screening able to provide compounds and data are sought to help develop and validate the liver-on-a-chip platform as an effective tool for drug development.
Ex vivo corneal model to assess ocular drug delivery
Industrial collaborators able to provide different classes of ocular drugs and drug penetration data are sought to further validate the ex vivo porcine corneal model.
LocoWhisk: Quantifying rodent locomotion behaviours
The LocoWhisk system incorporates both gait analysis and whisker movements and would benefit from further validation and commercialisation opportunities.
Vertex- simulating interventions on the mammalian brain
Industrial and academic collaborators are sought with expertise in various brain diseases and/or safety and efficacy of drug development to explore and expand the capabilities of the in silico model.
CombiDART: A non-vertebrate platform for rapid toxicity testing
Industrial partners able to provide chemicals and expert guidance are sought to help validate CombiDART (systems to rapidly assess compounds for developmental and reproductive toxicity) to meet their end-user needs.
Transnetyx Tissue: Processing of primary rat and mouse tissues
Transnetyx Tissue is seeking industrial and academic collaborators that require a reliable source of primary rat and mouse tissue and cells for research.
iSafeRabbit QSAR model for regulatory irritation/corrosion testing
The scope of iSafeRabbit HA-QSARs, an in silico model to predict the skin/eye irritation potential of chemical substances, needs to be extended and validated against new chemicals.
Animal Welfare Assessment Grid (AWAG)
Potential partners interested in adopting and trialling this software for capturing and visualising animal welfare assessment data, and willing to provide feedback to support refinement of the system are welcomed.
Cross-species comparative in silico platform (CRISP)
Moleculomics seek industry partners to help validate CRISP, a comparative in silico structural/functional platform for identifying species differences in liver activity, using in vitro and in vivo hepatotoxicity data.
MouseMet and RatMet: refined mechanical and thermal nociceptive testing
Topcat are looking for partners in pain research willing to assess MouseMet and RatMet, which provide an alternative approach to NTT testing, reducing the number of interventions required.